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Abstract 
Introduction:   The present study was carried out to evaluate the effect of Sitagliptin (Januvia) on the 
liver of experimentally induced diabetes in albino rats. 
Material and Methods: Fifteen adult male albino rats were used and divided into three equal groups. 
The first group was considered as a control group. In the second group experimental induction of 
diabetes was performed by intraperitoneal injection of alloxan and left as a diabetic control for three 
weeks.  The third group was consisted of rats of experimentally induced diabetes and treated by a daily 
dose of Sitagliptin (Januvia) as oral anti diabetic therapy for three weeks. 
Two main parameters were performed; the first was microscopic and histochemical studies on the liver 
tissue while the second was laboratory evaluation of some liver functions. 
Results: The hepatic tissue was affected by the experimental induction of diabetes in the form of 
cellular infiltration, hepatic cell cords disarrangement and vascular congestion after three weeks of 
induction. 
The fibrous elements as well as mucopolysaccharides contents were greatly reduced. Histochemical 
changes in the liver enzymes showed mild decrease. Liver function tests showed mild changes. 
Diabetic changes were gradually returned back to its normal state after the use of daily oral dose of 
Sitagliptin. 
Conclusions: The antidiabetic drug (Sitagliptin) could be considered a good therapy in limiting the 
risk of diabetes Mellitus on liver tissue. 
Keywords: Albino rats, Alloxan , Sitagliptin, structural and laboratory findings. 
 
Review of Literatures 
The  liver  has  a  wide  range  of  functions, 
including detoxification, protein synthesis and 
production  of  biochemicals  necessary  for 
digestion , glycogen storage, decomposition of 
red  blood  cells  and  hormone  production, 
(Maton et al., 1993). Hepatocytes make up 70 
to 80 % of the total mass of the liver. 
 
On  year  2000  at  least  171  million 
people  worldwide  suffer  from  diabetes 
mellitus,  or  2.8%  of  the  population,  type  II 
diabetes is by far the most common, affecting 
90  to  95%  of  the  U.S.  diabetes  population, 
(Lambert , 2002 and Wild et al, 2004). 
 
Diabetes  mellitus,  often  simply 
referred  to  as  diabetes  which  is  a  group  of 
metabolic  syndrome  characterized  by  high 
blood  sugar  level  and  classical  symptoms  of 
polyuria ,polydipsia and polyphagia .     There 
are  three  main  types  of  diabetes,  Type  I 
diabetes,  results  from  the  body's  failure  to 
produce  insulin  (insulin-dependent  diabetes 
mellitus, IDDM or juvenile diabetes).  Type II 
diabetes,  results  from  insulin  resistance,  a 
condition  in  which  cells  fail  to  use  insulin 
properly  (non-insulin-dependent  diabetes 
mellitus,  NIDDM  or  adult-onset  diabetes). 
Gestational diabetes; in pregnant women who 
have never had diabetes before and have a high 
blood  glucose  level  during  pregnancy.  It 
occurs in about 2%–5% of all pregnancies and 
may  improve  or  disappear  after  delivery 
(Rother, 2007). 
Diabetic  complications  may  be  acute 
in  the  form  of  hypoglycemia,  diabetic 
ketoacidosis,  or  nonketotic  hyperosmolar 
coma. Serious long-term complications include 
cardiovascular  disease,  chronic  renal  failure 
and retinal damage, (Rother, 2007). 
Pre-diabetes indicates a condition that 
occurs  when  a  person's  blood  glucose  levels 
are higher than normal but not high enough for 
a diagnosis of type  II  diabetes. Many people 
destined  to  develop  type  II  diabetes  spend The effect of Sitagliptin (Januvia) on the liver of adult Albino rats…  
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many years in a state of pre-diabetes which has 
been  termed  "America's  largest  healthcare 
epidemic, (Handelsman, 2009). 
Several  methods  have  been  used  to 
induce diabetes mellitus in laboratory animals 
with  variable  success  and  many  difficulties. 
Surgical  removal  of  the  pancreas  is  effective 
method;  however,  to  induce  diabetes  at  least 
90-95%  of  the  pancreas  has  to  be  removed, 
(Akbarzadeh et al., 2007). 
Induction  of  experimental  diabetes  in 
the rat using streptozotocin is very convenient 
and simple to use, (Ito, 1999). Streptozotocin 
injection  leads  to  the  degeneration  of  the 
Langerhans islets beta cells, (Ikebukuro et al., 
2002 and Takeshita et al., 2006). Clinically, 
symptoms of diabetes are clearly seen in rats 
within 2-4 days following single intravenous or 
intraperitoneal  injection  of  60mg/kg  STZ, 
(Elias et al., 1994).  
There  are  now  four  classes  of 
hypoglycemic  drugs,  Sulfonylureas, 
Metformin,Thiazolidinediones  and  Alpha-
glucosidase  inhibitors.  These  drugs  are 
approved for use only in patients with type II 
diabetes and are used in patients who have not 
responded  to  diet,  weight  reduction,  and 
exercise.  
Sitagliptin  (Januvia)  is  an  oral 
antidiabetic medicine that helps in controlling 
blood sugar levels. It acting through regulation 
of the insulin level in the blood.  
Sitagliptin is used in cases of type II 
diabetes.  It is sometimes used in combination 
with other anti diabetic medications, but is not 
for  treating  type  I  diabetes,  (Herman  et  al., 
2006). 
 
Material and Methods 
 
I.  Experimental animals: 
The  present  work  was  carried  out  on  15 
mature  male  albino  rats  weighting  100   ± 20 
gms. 
The  experimental  animals  were 
randomly  divided  into  three  groups  (5/cage). 
The  first  group  was  considered  as  a  control 
group  while  the  rest  of  all  animals  were 
subjected  to  the  induction  of  experimental 
diabetes  mellitus  by  single  intraperitoneal 
injection of freshly prepared alloxan in a dose 
120  mg/kg  dissolved  in  saline  solution, 
according to (Malaisse, 1982). 
Half of the induced diabetic rats were 
left as a control diabetic group (second group) 
while  the  rest  of  animals  represent  the  third 
group which were treated by the sitagliptin in a 
dose of 0.14 mg /100 gm body weight, (Paget, 
1964)  for  21  days  after  the  induction  of  the 
diabetes mellitus. 
II.  Preparation of microscopic sections: 
Liver was obtained and fixed in neutral 
buffered formol saline, (Clayden, 1971) for 5 
days, dehydrated ,cleared and  embedded in a 
hard grade of paraffin for 4 hours. 
Paraffin blocks were prepared and cut 
at  6  micrometers  thickness  using  a  rotary 
microtome. 
Different  staining  techniques  were 
used in this study including Heamtoxylin and 
Eosin stain, (Clayden, 1971). 
The  distribution  of collagenous fibers 
was performed by the use of Mallory trichrome 
stain,  (Tarkhan  1968),  while  periodic  acid-
schiff reaction was used for the distribution of 
mucopolysaccharide  contents  in  the  liver 
tissues. 
III. Histochemical techniques: 
       Frozen  sections  were  cut  at  15 
micrometers  thickness    for  demonstration  of 
the different enzymatic activity.  
      Modified  Gomori  method  for  Alkaline 
phosphatase enzyme  was used in this study, 
(Pearse, 1977).  Nitroblue tetrazolium method, 
(Nachlas et al., 1957) was used for localizing 
the activity of Succinic deydrogenase enzyme 
in the hepatic tissue. 
IV. Biochemical and laboratory data: 
Collection of rat’s serum: 
At the end of the experiment, animals 
were  decapitated  and  blood  samples  were 
collected  from  the  retro-orbital  plexus.  The 
samples were collected in clean dry graduated 
centrifuge tubes and left for 20 minutes to clot, 
then centrifuged at 5000 rpm, for 15 minutes. 
Using pasture pipette about half of the 
supernatant  serum  was  transferred  into  clean 
dry serology tubes for subsequent tests. Serum 
was separated and kept at -20ºC until analysis. 
1.  Assessment of serum glucose level: Serum 
glucose was estimated according to the 
enzymatic colorimetric method described 
by Trinder, (1984). 
2.  Determination of serum Insulin level: This 
method is carried out according to Reeves, 
(1983). Moustafa I.Hassan et al  
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3.  Alanine aminotransferase (ALAT): It was 
determined according to Breuer, (1996). 
4.  Gamma-Glutamyltransferase (GGT): It was 
determined by kinetic method according to 
Szasz and Persijn, (1974). 
V.  Statistical  analysis:  The  obtained  results 
were  tabulated  and  statistically  analyzed, 
Snedecor et al. (1980) 
 
     Results 
I.  Microscopic changes: 
a.  Control liver : 
Sections  in  control  liver  stained  by 
Hx&E  stain  shows  normal  hepatocytes 
arranged  in  radiating  cords  from  the  central 
vein  to  the  periphery  of  hepatic  lobule.  The 
cords are separated by hepatic sinusoids. 
Hepatocyte  contains  single  or 
sometimes  double  central  nuclei.  Region  of 
portal tract shows the normal tract contents of 
hepatic artery, portal vein and bile duct. (Fig. 
1,2). 
The  normal  distribution  of  the 
collagenous fibers around the region of portal 
tract were demonstrated in (Fig. 3) by Mallory 
stain technique. 
While  the  normal  hepatocyte  content 
of mucopolysacharride were seen in (Fig. 4). 
The  activity  of  alkaline  phosphatese 
enzyme in the control group seen in the (Fig. 
13),  while  the  activity  of  succinic 
dehydrogenase  enzyme  can  be  seen  in  (Fig. 
16). The obtained histochemical changes were 
confirmed  quantitatively by the use of image 
anaylsis system and statistically analyzed 
b.  Diabetic group:  
Induction  of  diabetes  by  alloxan 
greatly  affect  the  normal  structure  of  the 
different liver elements in the form of dilated 
congested central veins and hepatic cell cords 
disarrangement. (Fig. 5,6) 
The  distribution  of collagenous fibers 
in  diabetic  group  showed  increase  in  the 
collagen fibers around the region of portal tract 
(Fig.7). 
The  mucopolysacharrides  contents  in 
diabetic  group  show  marked  decrease  in  its 
distribution within the hepatocytes (Fig. 8). 
The  activity  of  alkaline  phosphatese 
and  succinic  dehydrogenase  enzymes  in 
diabetic  group  were  decreased  (Fig.  14,17). 
The  obtained  histochemical  changes  were 
confirmed  quantitatively by the use of image 
anaylsis system and statistically analyzed. 
c.  Effect of sitagliptin (Januvia):  
After oral intake of sitagliptin, the liver 
structure showed variable microscopic changes 
in the form of dilated congested central veins 
and mild cellular infiltrations at the region of 
portal tract (Fig9,10). 
The distributions of collagenous fibers 
were  slightly  decreased  but  do  not  return  to 
control  group  (Fig.  11),  while  the 
mucopolysacharrides  contents  in  the 
hepatocyte are more or less similar to those in 
the control group (Fig. 12). 
The  activity  of  both  alkaline 
phosphatese  and  succinic  dehydrogenase 
enzymes in this group returned back to near its 
normal  when  they  were  compared  to  the 
control  group  (Fig.15  and  18).  The  obtained 
histochemical  changes  were  confirmed 
quantitatively  by  the  use  of  image  anaylsis 
system and statistically analyzed. 
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( Fig.  1 ) Photomicrograph of a section in the control 
liver of albino rat showing the normal structure of the 
liver cells , Cells are arranged in cords radiating from the 
central vein ( Hx. & E.   X   200)  
 
( Fig.  3 ) Photomicrograph of a section in the control 
liver of albino rat showing the normal  distribution of the 
collagenous fiberes around the region of portal tract  
 ( Trichrome stain   X   250)  
 
 
( Fig.  2 ) Photomicrograph of a section in the control liver of 
albino rat showing the normal structure of the liver cells , the 
region of the portal tract is seen in the upper left of the figure. 
( Hx. & E.  X   200)  
 
 
( Fig.  4 ) Photomicrograph of a section in the control liver of 
albino rat showing the normal  distribution of PAS postive 
material in the liver cells (  PAS technique  X   250)  
 
1   2  
3  
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( Fig.5 ) Photomicrograph of a section in liver of induced 
diabetes of  albino rat showing dilated congested vein      
( Hx.E. stain   X   250)  
 
 
( Fig.7) Photomicrograph of a section in the liver of 
induced  diabetes of albino rat showing the  distribution of 
the collagenous fiberes around the region of portal tract ( 
Trichrome stain   X   250)  
 
 
(Fig.6) Photomicrograph of a section in liver of induced 
diabetes of  albino rat showing  hepatic cell cords 
disarrangement    ( Hx.E. stain   X   250)   
 
(Fig.8)Photomicrograph of a section in the liver of induced 
diabetes of albino rat showing the distribution of PAS 
postive material in the liver cells (  PAS technique  X   250)  
5  
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(Fig.9) Photomicrograph of  a section in induced 
diabetes and treated   by sitagliptin in the liver showing 
two dilated congested central veins   
 ( Hx.E. stain   X   250)  
 
( Fig.  11) Photomicrograph of  a section in induced 
diabetes and treated   by sitagliptin in the liver showing 
the distribution of the collagenous fiberes around the 
region of portal tract ( Trichrome stain   X   250)  
 
 
 
( Fig.10) Photomicrograph of  a section in induced diabetes 
and treated by sitagliptin in the liver showing) dilated 
congested vein and mild cellular infiltration at the region of 
portal tract.  ( Hx.E. stain X  200)       
 
( Fig.  12 ) Photomicrograph of  a section in induced diabetes 
and treated   by sitagliptin in the liver showing the 
distribution of PAS postive material in the liver cells   
(  PAS technique  X   250)   
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(Fig,13)Photomicrograph of  a section in control liver showing  
         alkaline phosphatase enzyme   (Modified Gomori stain x 200)    
 
13  
   
(Fig.14) Photomicrograph of  a section in induced 
diabetes in the liver showing alkaline phosphatase 
enzyme activity. (Modified Gomori stain     x 200)  
 
 
               
 
(Fig.15)Photomicrograph of  a section in induced diabetes 
and treated  by sitagliptin in the liver showing alkaline 
phosphatase enzyme activity. (Modified Gomori stain x 200)  
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(Fig 17)Photomicrograph of  a section in induced diabetes 
in liver showing succinic dehydrogenaze enzyme activities. 
 (Nachlas technique x 200 )  
 
 
(Fig 18)Photomicrograph of  a section in induced diabetes 
and treated by sitaglibtin in liver showing succinic 
dehydrogenaze enzyme activities  
 (Nachlas technique x 200)                                                                    
 
17  
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(Fig.16)Photomicrograph of  a section in control liver showing  
             succinic  dehydrogenaze enzyme activities.  
            (Nachlas technique    x 200)  
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 (Table 1) Changes in the mucopolysaccharide contents in the different groups of the study 
 
   Control  Diabetic  Treated 
1  1.12  0.36  1.02 
2  1.13  0.4  1 
3  1.16  0.45  1.02 
4  1.11  0.4  0.94 
5  1.12  0.42  1.12 
mean  1.128  0.406  1.02 
SD ±  0.019  0.033  0.065 
SE±  0.009  0.015  0.029 
Sig.     Sig.  Sig. 
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(Fig. 19)changes in mucopolysaccarides content in 
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(Table 2) Changes in the alkaline phosphatase enzyme activity  in the different groups of the study 
 
   Control  Diabetic  Treated 
1  1.52  0.5  1.02 
2  1.49  0.49  1.03 
3  1.4  0.5  0.91 
4  1.41  0.51  1.05 
5  1.39  0.49  1 
Mean  1.442  0.498  1.002 
SD ±  0.059  0.008  0.054 
SE±  0.026  0.004  0.024 
Sig.     Sig.  Sig. 
 
 
 
 
 
 
 
0 
0.2 
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Control  Diabetic  Treated 
(Fig. 20) changes in alkaline phosphatase 
enzyme activity in different groups of the study.  Moustafa I.Hassan et al  
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(Table 3) Changes in the succinic dehydrogenase enzyme activity in the different groups of the study 
 
   Control  Diabetic  Treated 
1  1.43  0.51  1.3 
2  1.35  0.49  1.07 
3  1.28  0.43  0.81 
4  1.4  0.52  0.9 
5  1.35  0.5  1.2 
Mean  1.362  0.49  1.056 
SD ±  0.057  0.035  0.203 
SE±  0.026  0.016  0.091 
Sig.     Sig.  Sig. 
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(Fig.21) changes in succinic dehydrogenase 
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   (Table 4) Changes in the blood glucose level in the different groups of the study 
 
 
G
l
u
c
o
s
e
  Control  Diabetic  Treated diabetes with Januvia 
Before 
(After) 
Time of 
sampling 
Before 
(After) 
Time of 
sampling 
Before  After 
Treatment 
1  121  123  272  252  276  78 
2  104  118  236  266  255  75 
3  101  119  243  256  241  103 
4  102  120  280  270  261  112 
5  114  120  215  233  259  89 
Mean  108.4  120  249.2  255.4  258.4  91.4 
SD ±  8.73  1.87  26.70  14.48  12.56  15.92 
SE ±  3.91  0.84  11.94  6.48  5.62  7.12 
Age comp.  Control : diabetic  Control : treated  Diabetic : treated 
T Value  20.730  3.991  17.041 
P value  ≥ 0.05  ≥ 0.05  ≥ 0.05 
Sig.  Sig.  Sig.  Sig. 
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 (Table 5) Changes in the serum insulin level in the different groups of the study 
 
 
I
n
s
u
l
i
n
 
Control  Diabetic  Treated diabetes with 
Januvia 
1  37  2.8  2 
2  32  2.4  2.1 
3  30  4.1  1.6 
4  29  4.5  2.4 
5  25  3.5  2.2 
Mean  30.6  3.46  2.06 
SD ±  4.39  0.87  0.30 
SE ±  1.96  0.39  0.13 
Age comp.  Control : diabetic  Control : treated  Diabetic : treated 
T Value  13.549  14.493  3.394 
P value  ≥ 0.05  ≥ 0.05  ≥ 0.05 
Sig.  Sig.  Sig.  Sig. 
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 (Table 6) Changes in serum level of Alanine amino transferase in the different groups of the study 
 
 
 
Control  Diabetic  Treated diabetes with 
Januvia 
1  58  79  81 
2  49  67  66 
3  44  57  90 
4  49  64  88 
5  65  72  89 
Mean  53  67.8  82.8 
SD ±  8.40  8.29  10.03 
SE ±  3.75  3.71  4.49 
Age comp.  C / D  C/ T  D / T 
T Value  2.805  5.093  2.577 
P value  ≥ 0.05  ≥ 0.05  ≥ 0.05 
Sig.  Sig.  Sig.  Sig. 
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(Table 7) Changes in serum level of (GGT) in the different groups of the study 
 
 
 
Control  Diabetic  Treated diabetes with 
Januvia 
1  1  2  1 
2  2  3  2 
3  4  2  1 
4  1  4  3 
5  1  3  1 
Mean  1.8  2.8  1.6 
SD ±  1.30  0.84  0.89 
SE ±  0.58  0.37  0.40 
Age comp.  C / D  C/ T  D / T 
T Value  1.443  0.283  2.191 
P value  ≤ 0.05  ≤ 0.05  ≤ 0.05 
Sig.  N Sig.  N Sig.  N Sig. 
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II.  Biochemical parameters: 
 
a.  Blood glucose level: 
There was change in the blood glucose 
level in the different groups of the study which 
appear  to  be  normal  in  control  group  and 
increased with induction of diabetes and return 
to normal level under the effect of sitagliptin 
(Table 4, Fig22). 
b.          Serum insulin level (u/ml):  
There was change in the serum insulin level in 
the different groups of the study which appear 
normal in control group and decreased in both 
diabetic  group  and  under  the  effect  of 
sitagliptin.(Table 5,Fig. 23) 
c.  Liver function tests: 
1.  Alanine amino transferase (ALAT): 
There  was  moderate  increase  in  the 
serum level of alanine amino transferase in the 
diabetic group which become highly increased 
in diabetes treated by sitagliptin group (Table 6 
, Fig 24). 
2.  Gama glutamic transferase (GGT):  
There  was  highly  increase  in  serum 
level of (GGT) in diabetic group which return 
back  to  normal  level  under  the  effect  of 
sitagliptin (Table7,Fig 25). 
 
DISCUSSION 
 
 In  this  study,  adult  male  albino  rats  were 
used and divided into three equal groups. The 
first group was considered as a control. In the 
second  group  experimental  induction  of 
diabetes  was  performed  by  intraperitoneal 
injection  of  alloxan  and  left  as  a  diabetic 
control for three weeks .  The third group was 
consisted  of  rats  of  experimentally  induced 
diabetes  and  treated  by  a  daily  dose  of 
Sitagliptin (Januvia) drug in a dose of 0.14 mg 
/100 gm body weight, (Paget, 1964) for three 
weeks. 
In  the  present  study  ,  the  microscopic 
examination  of  the  rat's  liver  in  the  second 
group (induced diabetes) was greatly affecting 
the  normal  structure  of  the  liver  cellular 
elements  in  the  form  of  dilated  congested 
central  veins  ,  hepatic  cell  cords 
disarrangement , increase in the collagen fibers 
around the region of portal tract and decrease 
distribution of hepatic mucopolysacharrides. 
Hramiak  et  al.,  1997,  support our results 
and  stated  that  in  newly  diagnosed  diabetes 
showed higher long-term risk of serious liver 
affections,  including  cirrhosis  and  liver  cell 
failure.  
In  experimentally  diabetic  treated  rats  with 
oral  intake  of  sitagliptin  in  group  3 
microscopic  examination  of  the  liver  showed 
variable  microscopic  changes  in  the  form  of 
dilated  congested  central  veins  and  mild 
cellular  infiltrations  at  the  region  of  portal 
tract.   The distributions of collagenous fibers 
were slightly decreased but do not return to its 
normal  architecture  as  in  the  control  group 
,while the mucopolysacharrides contents in the 
hepatocytes were more or less similar to those 
in the control group . 
Horn  et  al.,  (1995)  reported  that  the 
presence  of  collagen  in  the  presinusoidal 
spaces might affected the blood supply to liver 
cells  and  would  be  reduce  the  exchange  of 
metabolism,  perhaps  causing  hepatocellular 
dysfunction and necrosis. 
Sitagliptin  is  a  new  class  of  oral  anti-
hyperglycemic  drugs  known  as  a  DPP-4 
inhibitor or incretin enhancer for the treatment 
of  Type  II  diabetes  mellitus,  (Amori  et  al, 
2007).  Clinical  studies  have  shown 
improvement in beta-cell function, suggesting 
a  potential  for  preservation  of  beta-cells, 
(Richter, et al.2008). 
Abnormalities  of  triglyceride  storage  and 
lipolysis in insulin-sensitive tissues such as the 
liver lead to abnormal morphological changes 
in  hepatocytes,  (Neuschwander-Tetri  et  al., 
2003). 
In  insulin  resistance  characteristic  of  type 
II, there is increase in the uptake and storage of 
triglycerides fats from the diet, abdominal fat 
and nearby muscles into compartments within 
the hepatocyte vesicles. This infiltration of fat 
is  called  steatosis.  The  results  are  fatty  liver 
which  is  larger  than  normal,  (Standards  of 
medical care in diabetes 2011). 
Elevated  activities  of  serum 
aminotransferases are a common sign of liver 
diseases  and  are  observed  more  frequently 
among  people  with  diabetes  than  in  general 
population,  (Arkkila  et  al.,  2001).  Serum 
ALAT, AST and ALP levels were determined 
to  evaluate  the  hepatic  functions, 
(Degirmenchi  et  al.,  2002).  The  increase  in 
aminotransferases  levels  may  be  due  to  the 
cellular damage in the liver caused by alloxan-
induced  diabetes.  Although  ALAT  is  also 
present  in  mitochondria  and  cytosol,  the 
mitochondrial  form  is  low  in  activity  and  is 
very  unstable.  The  detailed  mechanism  by Moustafa I.Hassan et al  
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which  enzymes are released from the cytosol 
and  mitochondria  of  hepatocytes  is  not 
completely known. 
Experimental  studies  have  shown  that 
subtle  membrane  changes  are  sufficient  to 
allow passage of intracellular enzymes to the 
extracellular space, Garella, (1997).Very large 
concentration gradient between the hepatocytes 
and  the  sinusoidal  space  usually  exists  for 
enzymes.  Cell  damage  increases  permeability 
causing cytosolic isoenzymes to spill into the 
sinusoids  and  from  there  into  the  peripheral 
blood, Garella, (1997). 
Baxter and Schofield, (1980) reported an 
increase in AST and ALAT in diabetics. This 
alteration in hepatic function may be because 
of  increase  activity  and  mRNA  levels  of 
araginase  as  reported  by  Salimuddin  et  al. 
(2008). 
 Increase in the levels of ALP in diabetic rats 
was  also  reported  by  Ramesh  & 
Pugalendi,(2006). 
Insulin  regulates  the  entry  of  glucose  into 
tissues and promotes glycogen storage. Insulin 
is metabolized in the liver, where it promotes 
the  production  of  glycogen,  protein, 
cholesterol,  and  triglycerides  and  stimulates 
the  formation  of  low  density  lipoproteins 
(LDL),  which  transport  cholesterol  into  the 
arteries.  In  diabetes,  excessive  output  of 
glucose  by  the  liver  contributes  to  elevated 
fasting blood sugars, Ghishan ,( 1996). 
Davidson  et  al.,  (2009)  reported  that 
sitagliptin  enhance  the  body's  own  ability  to 
control blood glucose by increasing the active 
levels of incretin hormones in the body. 
Sitagliptin  (DPP-4  inhibitors)  control 
elevated blood glucose by triggering pancreatic 
insulin  secretion,  suppressing  pancreatic 
glucagon secretion, and signaling the  liver to 
reduce glucose production. This study open the 
door for further investigations of other recent 
oral  antidiabetic  therapy  for  better 
improvement  of  different  diabetic 
complications.
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 نيتبيلجاتيسلا راقع ريثأت ( ايفونيجلا  )  ركسلا ضرم تلااح يف هغلابلا ءاضيبلا ناذرجلا دبك  ىلع  
يبيرجتلا    ( ةيلمعمو ةيبوكسوركيم ةسارد )  
 
 
  نسح ليعامسإ ىفطصم
6        ىوابرغلا ناميلس لامج
6        ىفطصم داوجلا دبع ىنغلا دبع
2  
سهلا ماسقأ نم ت ولو  بطلا تايلكب ايج  (  ةرهاقلا
6   طايمدو
2  ) رـــــــــهزلأا ةعماج  
 
 
 نيتبيلجاتيسلا راقع ريثأت  مييقتل ةساردلا هذه ءارجإ مت  ( ايفونيجلا  ) ح ىف ةغلابلا ءاضيبلا ناذرجلا دبك يلع  تلاا
ضرم   ىبيرجتلا  ىركسلا لوبلا .  
 مادختسا مت 51    يلإ تمسق ثيح ةغلابلا ءاضيبلا ناذرجلا روكذ نم 3   ةيواستم تاعومجم  , لا تربتعا  ةعومجم
 لخاد ناسكوللأا راقعب اهنقح دعب يركسلا لوبلا ضرمب اهتباصإ مت دقف ةيناثلا ةعومجملا امأ هطباض هعومجم يلولأا
 مت ةثلاثلا ةعومجملا ىفو  ينوتيربلا ءاشغلا إ  نيتبيلجاتيسلا راقع مادختس ( ايفونيجلا   )  لوبلا ضرم جلاع ىف مفلا قيرط نع
 اهردق ةعرجب ىبيرجتلا ىركسلا 1.54    لكل مارجيلم 511   ةمدختسملا ناذرجلا نزو نم مارج  .  
  دقو إ  ةدمل  مدختسملا راقعلاب جلاعلارمتس 15    ضرملا ثادحإ خيرات نم اموي .  
 
 ىلإ جئاتنلا ميسقت متو إ ا لمش نيفلتخم نيهاجت لإ  تارييغتلا عبتتل دبكلا ايلاخل ةيبوكسوركيم ةسارد لولأا هاجت
 تاعومجملا يف اهثودح لمتحملا  مييقت بناجب دبكلا فئاظو ضعبل ىلمعم ليلحت نع ةرابع وهف يناثلا هاجتلإا امأ  ةفلتخملا
 ةفلتخملا تاعومجملا يف سايركنبلاو دبكلا ايلاخ ةءافك يدم رهظت يتلاو مدلا ىف نيلوسنلأاو ركسلا ةبسنل ىمك .  
 
ا ةدايز ىف يركسلا لوبلا ضرمب دبكلا ايلاخ رثأت يدم يلع جئاتنلا تلد دقو  ماظتنإ مدعو ةيولخلا تابيسرتل
و دبكلا ايلاخل ىبوكسوركيملا بيترتلا إ  ةيجنلاوكلا فايللأا ةيمك ىف حضاو ضافخنإ ظحول امك ةيومدلا هيعولأا يف ناقتح
كو دياراكسى يلوبوكويملا ةدام نم لك ةبسنو ذ ا طاشنلا كل لإ ايلاخلا هذه ىف ىميزن  .  
 ناك دقلو لإ  رثأ نيتبيلجاتيسلا راقع مادختس  ايلاخل ةيعيبطلا ةروصلا ىلإ اهتدوعو تارييغتلا كلت نسحت ىف حضاو
دبكلا  . روصلا نسحت ىف مدختسملا راقعلا ةيلعاف ىدم ىلع ةيلمعملا جئاتنلا تلد دقو ة   ةيعيبطلا ةلاحلل اهتدوعو ةيضرملا .  
 
 ةساردلا هذه نم جتنتسيو أ  نيتبيلجاتيسلا راقع ن ( ايفونيجلا   ) ضملا نيسحت يف ديج رود هل  نع ةجتانلا تافعا
 دبكلا ايلاخ  يلع ىركسلا لوبلا ضرم ريثأت .    
 
 
 
 